Status:

COMPLETED

Relative Levels of BMS-986036 in Blood Plasma in Healthy, Overweight, and Obese Participants Following Subcutaneous Administration Via Auto-injector Versus Pre-filled Syringe

Lead Sponsor:

Bristol-Myers Squibb

Conditions:

Healthy Participants

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to develop an auto-injector (AI) device for the BMS-986036 subcutaneous formulation that can be self-administered conveniently by participants.

Eligibility Criteria

Inclusion

  • For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
  • Healthy, overweight, obese, male and female participants, as determined by normal in medical history, physical examination (PE), electrocardiograms (ECGs), and clinical laboratory determinations
  • Body mass index (BMI) of 25.0 kg/m2 to 40.0 kg/m2, inclusive i) Approximately 25% of participants will be overweight and have a BMI between 25 kg/m2 and 30 kg/m2, inclusive ii) Approximately 75% of participants will be obese and have a BMI \> 30 kg/m2 to ≤ 40 kg/m2
  • Women and men must agree to follow specific methods of contraception, if applicable, while participating in the trial

Exclusion

  • Women who are pregnant or breastfeeding
  • Inability to tolerate subcutaneous (SC) injections
  • Inability to be venipunctured and/or tolerate venous access
  • Any sound medical, psychiatric, and/or social reason as determined by the investigator
  • Other protocol-defined inclusion/exclusion criteria apply

Key Trial Info

Start Date :

July 29 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 11 2021

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT04493567

Start Date

July 29 2020

End Date

June 11 2021

Last Update

March 18 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Anaheim Clinical Trials

Anaheim, California, United States, 92801

2

ICON (LPRA) - Salt Lake

Salt Lake City, Utah, United States, 84124